The Patent Finder

Bromodomain Inhibitors

Celgene Corporation

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 7 of these applications claim priority to application 61/893,133, filed Oct 18, 2013. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 9,034,900Bromodomain Inhibitors
In force
 · High confidence
Celgene Quanticel Research, Inc.In force
High confidence
US 9,115,114Bromodomain Inhibitors
In force
 · High confidence
Celgene Quanticel Research, Inc.In force
High confidence
US 9,598,372Bromodomain Inhibitors
In force
 · High confidence
Celgene Quanticel Research, Inc.In force
High confidence
US 10,023,592Bromodomain Inhibitors
In force
 · High confidence
Celgene Quanticel Research, Inc.In force
High confidence
US 10,562,915Bromodomain Inhibitors
In force
 · Medium confidence
Celgene Quanticel Research, Inc.In force
Medium confidence
US 10,941,160Bromodomain Inhibitors
In force
 · High confidence
Celgene Quanticel Research, Inc.In force
High confidence
US 11,884,680Bromodomain Inhibitors
In force
 · High confidence
Celgene Quanticel Research, Inc.In force
High confidence
Application 18/531,630Bromodomain Inhibitors
Pending
Not granted
Celgene Quanticel Research, Inc.PendingNot granted
8 of 8 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
7 of these are in force and held by Celgene Corporation.
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited